-
AbbVie and Pfizer return to the top of pharma's TV spending list for February
fiercepharma
March 07, 2019
AbbVie’s Humira is back—at the top of the pharma TV ad spending pile, that is. In February, Humira was the No. 1 spender again, according to data from real-time TV ad tracker iSpot.tv, swapping places with Pfizer’s?Xeljanz.
-
AbbVie and Pfizer return to the top of pharma's TV spending list for February
fiercepharma
March 07, 2019
AbbVie’s Humira is back—at the top of the pharma TV ad spending pile, that is. In February, Humira was the No. 1 spender again, according to data from real-time TV ad tracker iSpot.tv, swapping places with Pfizer’s?Xeljanz.
-
Top 10 drugs losing exclusivity in 2019
fiercepharma
March 06, 2019
Pharma companies do their best to fight off patent expirations and generic competition as long as possible to protect their big moneymakers. But this year looks like the end of the line for many of the industry's top brands.
-
Pharma drug delivery market worth $1,694.7 billion by 2023
europeanpharmaceuticalreview
March 06, 2019
The pharmaceutical drug delivery market could reach $1,694.7 billion by 2023, increasing at a CAGR of 6.4 percent during the period…
-
Pharma Can BMS rebels scuttle its Celgene buy? Analysts do the math—and so far, the votes don't add up
fiercepharma
March 04, 2019
Bristol-Myers Squibb shareholders panicked on Wednesday when its largest institutional shareholder, Wellington Management, came out against its $74 billion acquisition of Celgene—and activist hedge fund Starboard Value immediately followed suit.
-
Top 10 drugs losing exclusivity in 2019
fiercepharma
March 04, 2019
Pharma companies do their best to fight off patent expirations and generic competition as long as possible to protect their big moneymakers. But this year looks?like the end of the line for many of the industry's top brands.
-
Pharma in South East Asia booming as CPhI to open event in Thailand
en-cphi.cn
March 01, 2019
CPhI South East Asia’s first visit to Bangkok has stimulated a market resurgence, with pre-registration numbers tripling and exhibition growth of 50%
-
Expansion of the global antibiotics market size
europeanpharmaceuticalreview
March 01, 2019
The global antibiotics market is set to increase at a CAGR of 4 percent to $62.06 billion, due to the rising prevalence of infectious diseases…
-
Pharma CEOs grilled by US Senators over drug prices
pharmaphorum
February 28, 2019
Pharma bosses faced a grilling from the US Senate’s Finance Committee over the high price of branded prescription drugs in the US compared with other developed countries.
-
Philly council nixes pharma gift ban, sales rep rules
fiercepharma
February 24, 2019
Pharma just scored a big win in Philly. A proposed crackdown on pharma gifts and?sales representatives was resoundingly voted down Thursday by Philadelphia's city council, which came out 9-5 against the measure.